Lithotripsy for the Treatment of Gallstones
Primary Purpose
Cholelithiasis
Status
Terminated
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Extracorporeal Shock Wave Lithotripsy
ursodiol
Sponsored by
About this trial
This is an interventional treatment trial for Cholelithiasis focused on measuring Gallstones, Gallstone, Biliary stones, Gallbladder stones, Gallbladder, Lithotripsy, Cholelithiasis, ESWL, Shock wave, Shock waves, shockwaves, shockwave
Eligibility Criteria
History of biliary pain Evidence of a single noncalcified, radiolucent gallstone between 4 and 20 mm (inclusive) diameter HIDA scan demonstrating patency of cystic bile duct No cardiac pacemaker No allergy to radioopaque dye, iodine, bile acids No spontaneous or iatrogenic bleeding disorder No current or prior bile duct obstruction, cholangitis, pancreatitis, or cholecystitis Not pregnant
Sites / Locations
- The Methodist Hospital
- Virgina Commonwealth University
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00042549
Brief Title
Lithotripsy for the Treatment of Gallstones
Official Title
Biliary Lithotripsy in Combination With Actigall Versus Actigall Monotherapy for the Treatment of Symptomatic Cholesterol Gallstones
Study Type
Interventional
2. Study Status
Record Verification Date
June 2003
Overall Recruitment Status
Terminated
Study Start Date
May 2002 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Medstone International
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to determine the effectiveness and safety of using the Medstone lithotripter to treat single non-calcified gallstones from 4 to 20 mm in diameter.
Detailed Description
This study is a randomized, single-masked controlled trial in which the combination therapy of lithotripsy and the bile acid drug Actigall is compared to monotherapy with only Actigall. The primary objectives are, 1) To determine whether the use of the Medstone STS Lithotripter system in combination with the orally administered drug Actigall is more effective (as measured by percentages of stone free patients 6 months after randomization) in reducing single non-calcified radiolucent gallstones (from 4 to 20mm in diameter) than use of Actigall alone, and 2) To demonstrate that use of the Medstone lithotripsy system is safe (as measured by incidence of adverse events) for the intended purpose, when operated according to its labeling.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cholelithiasis
Keywords
Gallstones, Gallstone, Biliary stones, Gallbladder stones, Gallbladder, Lithotripsy, Cholelithiasis, ESWL, Shock wave, Shock waves, shockwaves, shockwave
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Single
Allocation
Randomized
Enrollment
184 (false)
8. Arms, Groups, and Interventions
Intervention Type
Device
Intervention Name(s)
Extracorporeal Shock Wave Lithotripsy
Intervention Type
Drug
Intervention Name(s)
ursodiol
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
History of biliary pain
Evidence of a single noncalcified, radiolucent gallstone between 4 and 20 mm (inclusive) diameter
HIDA scan demonstrating patency of cystic bile duct
No cardiac pacemaker
No allergy to radioopaque dye, iodine, bile acids
No spontaneous or iatrogenic bleeding disorder
No current or prior bile duct obstruction, cholangitis, pancreatitis, or cholecystitis
Not pregnant
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Atilla Ertan, M.D.
Organizational Affiliation
The Methodist Hospital Research Institute
Official's Role
Study Director
Facility Information:
Facility Name
The Methodist Hospital
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Facility Name
Virgina Commonwealth University
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23298
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
12003415
Citation
Ertan A. Treatment of gallstones by extracorporeal shock wave lithotripsy. Am J Gastroenterol. 2002 Apr;97(4):831-2. doi: 10.1111/j.1572-0241.2002.05738.x. No abstract available.
Results Reference
background
PubMed Identifier
1612339
Citation
Ertan A, Hernandez RE, Campeau RJ, Geshner JR, Litwin MS. Extracorporeal shock-wave lithotripsy and ursodiol versus ursodiol alone in the treatment of gallstones. Gastroenterology. 1992 Jul;103(1):311-6. doi: 10.1016/0016-5085(92)91128-q.
Results Reference
background
PubMed Identifier
2672841
Citation
Vanderpool D, Jones RC, O'Leary JP, Hamilton JK. Biliary lithotripsy. Am J Surg. 1989 Sep;158(3):194-7. doi: 10.1016/0002-9610(89)90251-1.
Results Reference
background
PubMed Identifier
1987875
Citation
Sackmann M, Pauletzki J, Sauerbruch T, Holl J, Schelling G, Paumgartner G. The Munich Gallbladder Lithotripsy Study. Results of the first 5 years with 711 patients. Ann Intern Med. 1991 Feb 15;114(4):290-6. doi: 10.7326/0003-4819-114-4-290.
Results Reference
background
PubMed Identifier
8655959
Citation
Pelletier G, Raymond JM, Capdeville R, Mosnier H, Caroli-Bosc FX. Gallstone recurrence after successful lithotripsy. J Hepatol. 1995 Oct;23(4):420-3. doi: 10.1016/0168-8278(95)80200-2.
Results Reference
background
Links:
URL
http://patients.uptodate.com/frames.asp?page=tocmain.asp
Description
UpToDate is a practical clinical information service (always current). It is written by a recognized faculty of experts who each address a specific clinical issue. They synthesize the latest evidence and best practices.
Learn more about this trial
Lithotripsy for the Treatment of Gallstones
We'll reach out to this number within 24 hrs